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Background:  In 2013,  Prince  Edward  Island  was  the  ﬁrst province  to introduce  HPV  vaccine  universally
to  grade  six  boys  in  a school-based  program.  Because  uptake  rates  in  boys  are  unknown  in  this  type  of
vaccination  program,  uptake  of  HPV  vaccination  in  boys  was  measured  and  compared  with  uptake  rates
in  girls  and  then  analyzed  with  factors  such  as  county,  urban–rural  location  of the  school,  and  school
board  to  identify  where  the  vaccine  program  could  be improved.
Methods:  HPV  vaccination  records  from  the  provincial  childhood  immunization  registry  in  PEI  were
merged  with  Department  of Education  data  containing  all  grade  six  girls  and  boys  in  PEI.  Vaccine  uptakes
between  years  and  between  sexes  were  compared  using  two  sample  tests  of  proportions.  Logistic  regres-
sion modeling  which  accounted  for the  hierarchical  nature  of  the  data  was  used  to  analyze  associations
between  factors  and  uptake  rates.
Results:  Although  uptake  was  high  in  boys  and  girls,  a  signiﬁcantly  greater  proportion  of  girls  (85%)
received  all  three  doses  of the  HPV  vaccine  compared  to  boys  (79%;  p =  0.004).  The odds  of grade  six girls
being  fully  vaccinated  for HPV  were  1.5  times  greater  than  of  grade  six boys,  and  the  odds  of  students  in
the English  Language  School  Board  receiving  all three  doses  were  more  than  twice  as  great  as  the  odds
of French  Language  School  Board  students.
Conclusions:  HPV  vaccination  for  boys  in PEI  has  had  a successful  launch,  almost  reaching  the  Canadian
Immunization  Committee  recommendations  of  >80%  for the  early  years  of  a program.  PEI has  a  highly
organized  Public  Health  Nursing  program  that  is involved  in  all childhood  and  school-based  vaccinations
in  PEI  and  in  this  context  very  high  coverage  rates  were  obtained.  Areas  to target for  improving  uptake
include  the  boys  and  the  students  in  the  French  Language  School  Board.
© 2015  The  Authors.  Published  by Elsevier  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND. Introduction
The World Health Organization recognizes human papillo-
avirus (HPV) as the most common sexually transmitted infection
n the world [1]. Although cervical cancer is the most common can-
er caused by HPV, other cancers associated with HPV infection
re squamous cell carcinomas of the anus, vagina, vulva, penis, and
he oropharynx (the base of the tongue, the tonsil, and pharynx)
2]. Approximately 43–88% of these different anogenital cancers
orldwide and 56% of oral cancers in North America are associ-
ted with HPV infection [3–5]. In addition, HPV (mainly types 6
∗ Corresponding author. Tel.: +1 902 368 5101; fax: +1 902 620 3354.
E-mail addresses: cmcclure@ihis.org (C.A. McClure), mamacswain@ihis.org
M.-A. MacSwain), cjsanford@gov.pe.ca (C.J. Sanford).
ttp://dx.doi.org/10.1016/j.vaccine.2015.02.047
264-410X/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article unlicense  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
and 11) cause warts in the anogenital areas including the anus,
penis, vagina, and vulva [6]. Genital warts are common having an
annual incidence between 1 and 2 cases per 1000 people in North
America [7]. They are highly infectious and cause signiﬁcant direct
health care costs as well as indirect costs including psychosocial
harm [8–10]. Although rare, recurrent respiratory papillomatosis
is also caused by HPV [11].
In the fall of 2008 an HPV vaccination program was initiated in
grade 6 girls in Prince Edward Island (PEI)1, Canada. In February
2010, Health Canada approved the use of the quadrivalent HPV
vaccine in boys aged 9–12. By January 2012, the National Advisory
Committee on Immunization (NACI) (see footnote 1) recommended
1 Abbreviations: Prince Edward Island (PEI), National Advisory Committee on
Immunization (NACI).
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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he use of HPV vaccine to protect males against intraepithelial neo-
lasia, anal cancer and anogenital warts [12]. In 2013, PEI was the
rst province to introduce HPV vaccine universally to boys in grade
. In 2014, Alberta added boys to their HPV vaccination program
13].
Increasing the proportion of the population that is vaccinated
ill decrease the risk of individuals becoming infected either
irectly or indirectly from the herd effect [6,14]. This is a major
im of a successful vaccination program. Unfortunately, vaccina-
ion uptake by boys in the United States has been quite variable
nd not very high [15–18]. Quantiﬁcation of the uptake of HPV vac-
ines in both boys and girls in PEI is necessary to ensure successful
elivery of the school-based program.
The aims of this study were two fold. The ﬁrst aim was  to mea-
ure the uptake of HPV vaccination in boys after the ﬁrst year of the
niversal school-based program. The second aim was to determine
f there were any changes in the girls’ recent uptake rate relative to
revious years. Additionally, the relationships between HPV vac-
ination and factors such as county, urban–rural location of the
chool, and school board were analyzed to identify areas where the
accine program could be improved.
. Methods
.1. Description of vaccine program and student status
The PEI HPV vaccine program is a school-based program that
s administered by Public Health Nursing and covers all grade six
irls and boys. A speciﬁc Public Health Nurse is assigned to every
chool in PEI. Prior to vaccine delivery, an information package that
ncludes a parental consent form, a fact sheet, and a Question and
nswer document is sent home with students. The consent must
e signed and returned to Public Health prior to the immunization
ate. If consent forms are not returned prior to the date of vaccine
elivery or if consent has been refused, a public health nurse will
hone the parent or guardian to discuss the HPV immunization and
nswer questions. At the end of the phone call, parents may  give
onsent or a refusal. The three doses of vaccine are administered by
he school Public Health Nurse and additional Public Health Nurses
s deemed necessary based on the grade 6 population. Students
re immunized by class, both boys and girls together using the
ACI recommended schedule [19]. All three doses are required to
e considered fully immunized.
.2. Data collation and analyses
An extract of HPV vaccination records from September 1, 2013
o September 2, 2014 were received from the provincial child-
ood immunization registry in PEI. These records were merged
ith a dataset provided by the Department of Education contain-
ng all grade 6 girls and boys in PEI for the 2013–2014 school year,
sing a minimum of two common identiﬁers. In cases where a stu-
ent’s record was found to be incomplete, vaccination records were
ndividually reviewed, and where possible data were extracted
anually. Students were not counted in the analysis if there was
able 1
PV vaccine dose uptake by school year and sex.
2008–2009 2011–2012 20
Girls (n = 801) Girls (n = 731) G
% n % n % 
One dose 87.6 702 87.3 638 90
Two  doses 84.9 680 86.7 634 90
Three  doses 81.1 650 85.1 622 8733 (2015) 1786–1790 1787
evidence to show a student had moved, received HPV  vaccine doses
in another province or a previous school year, or refused the vaccine
for legitimate medical reasons. Vaccine uptake rates in girls from
previous school years (2008–2009, 2011–2012, and 2012–2013)
were calculated similarly with the exception of the 2008–2009
school year in which only the number of grade 6 girls attending all
PEI schools was provided as a denominator for the uptake rate. Vac-
cine uptake rates between years and between sexes were compared
using two sample tests of proportions.
Unconditional associations between predictors and the out-
come (fully immunized or not) were tested using chi square
analysis, and those with a p-value <0.20 were retained for inves-
tigation in the multivariable model. A logistic regression model
was used which accounted for the hierarchical nature of the data
(students clustered in schools, schools clustered in school boards)
by controlling for clustering of individual schools using robust
standard errors and using school board as a ﬁxed effect. This model
was repeated two more times using vaccine initiation (≥1 dose)
and receipt of 2 or more doses as the outcome measure. All analyses
were conducted using Stata 13.1 [20].
3. Results
Of the 1443 students registered in the school system, 1349 (93%)
records merged with the immunization database. Of the remaining
94 (7%) unmerged records, 50 had data entry issues and eventu-
ally merged while the remaining 44 (3%) records did not have a
corresponding record in the immunization database. Three records
were excluded from the analysis because the vaccine was  refused
for legitimate medical reasons or the student had moved in or out
of the province during the school year. The ﬁnal 2013–2014 grade
6 cohort consisted of 725 boys and 715 girls. Of these students, 242
(17%) received at least one dose outside of the school vaccination
clinic. Thirty-eight (3%) had an indication that they had missed a
school clinic or that they needed to make an appointment with
Public Health Nursing for their vaccine but failed to get their ﬁnal
dose.
Although uptake was  high in boys and girls, a signiﬁcantly
greater proportion of girls (85%) received all three doses of the
HPV vaccine compared to boys (79%; p = 0.004). The proportion
of grade 6 girls who received all three doses for HPV vaccine has
increased signiﬁcantly since the start of the program, from 81% in
the 2008–2009 school year, to 85% in the 2013–2014 school year
(p = 0.03) (Table 1). The pattern of uptake is similar across the years
with the decrease in the number of students between the sec-
ond and third dose larger than the decrease in number of students
between the ﬁrst and second dose.
Results of unconditional associations between complete immu-
nization status and predictors are displayed in Table 2. Sex of the
student and school board were included in a multivariable logistic
model which controlled for clustering by individual schools (n = 43)
using robust standard errors. Both sex and school board signiﬁ-
cantly predicted immunization status (Table 3). More speciﬁcally,
the odds of grade 6 girls being fully vaccinated for HPV were 1.5
times greater than of grade 6 boys (OR = 1.50, 95% CI 1.14–1.98).
12–2013 2013–2014
irls (n = 678) Girls (n = 715) Boys (n = 725)
n % n % n
.7 615 90.6 648 85.4 619
.3 612 88.7 634 83.0 602
.3 592 84.9 607 79.0 573
1788 C.A. McClure et al. / Vaccine 
Table  2
Unconditional associations between individual factors and vaccination uptake for
three doses.
Fully immunized p
% n
Sex 0.004
Female (n = 715) 84.9 607
Male (n = 725) 79.0 573
School board 0.004
English (n = 1365) 82.6 1128
French (n = 75) 69.3 52
School location 0.972
Urban (n = 810) 82.0 664
Rural (n = 630) 81.9 516
School county 0.321
Prince (n = 487) 83.8 408
Kings (n = 171) 79.0 135
Queens (n = 782) 81.5 637
Table 3
Multivariable logistic regression model for vaccination uptake for three doses.
 (SE) OR 95% CI p
Overall 0.006
Sex  0.004
Female (n = 715) 0.406 (0.140) 1.50 1.14–1.98
Male (n = 725) Ref
School board 0.005
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French (n = 75) Ref
dditionally, the odds of students in the English Language School
oard receiving all three doses were more than twice as great as the
dds of French Language School Board students (OR = 2.14, 95% CI
.25–3.66). Results of modeling using ≥1 dose and ≥2 doses as the
utcomes were similar to using complete vaccination status (data
ot shown).
. Discussion
To our knowledge, this is the ﬁrst report of HPV vaccine uptake
or boys in a school-based program. Boys had a successful ﬁrst
ear and their uptake is comparable to the results of the girls in
008–2009 when their program was initiated. Historically PEI has
ad good uptake for HPV vaccine in girls. Rates of HPV uptake for
irls across Canada vary greatly. The Canadian Immunization Com-
ittee have set a benchmark of ≥80% fully vaccinated in the early
ears of the program [21]. Uptake of HPV vaccine in girls appears
o be lower in Ontario and westward compared with Quebec and
he Atlantic provinces [22,23]. Various surveys, including sentinel
ites, have been conducted in the United States and have demon-
trated uptake of HPV vaccine in boys (≥1 dose) to vary between
.8% and 20% [15–18]. PEI is fortunate to have a public-health deliv-
red immunization program which has seen much success in the
mplementation of new vaccines in the province [24]. Having spe-
iﬁc nurses assigned to individual schools in PEI works well in
uilding relationships and trust between the teachers and adminis-
ration at the schools and to some extent the parents. In addition to
chool-based immunizations, these nurses are the primary point of
ontact for any health-related issues that may  come up at the school
uch as disease follow-up, contact tracing or reporting of school
utbreaks. The nurses also build rapport with the school popula-
ion by training teachers, parents and volunteers how to conduct
chool-wide head checks for lice detection and prevention. Having
edicated public health nurses assigned to school-based programs
lso increases parental engagement and satisfaction and is asso-
iated with an increased likelihood of HPV vaccine initiation and
ompletion [25]. Using the public health nurses to deliver the HPV33 (2015) 1786–1790
vaccination program in schools is likely one reason for the high
acceptance and completion rates of HPV vaccination in both boys
and girls.
The trend in uptake starts with a very high rate of students
receiving the initial dose. A slight decrease in rate is seen for the
second dose and a larger drop occurs for the third dose. It is pos-
sible that this lag for the third dose is due to logistical issues as
3% of the students in 2013–2014 school year did not get their
ﬁnal dose even though they had at least one vaccine and had a
comment about missing the school clinic or needing to make an
appointment for the vaccine. Students have three opportunities to
be immunized within their school setting. If they miss the ﬁrst
dose, then there are two more opportunities to be immunized
at school. After that, the student would be required to make an
appointment for the third and ﬁnal immunization at a Public Health
Nursing ofﬁce and that could present a barrier for some. This sim-
ilar trend of attrition is found in girls in other Atlantic provinces
for almost all of the years of vaccination [26,27] which further
supports a logistical barrier to receiving a third dose if it is not
possible to receive the vaccine at school where it is highly conve-
nient.
Although 79% of grade six boys had received three doses of HPV
vaccine, they were signiﬁcantly less likely to be immunized than the
girls (85%). This signiﬁcant difference was found when the outcome
was 1 dose, 2 doses, or fully immunized in the model and therefore
was a difference in terms of intention to vaccinate. Having lower
rates in boys than girls is consistent with multiple jurisdictions in
the United States [15,17,28]. In these studies, none of the adoles-
cent boy groups achieved an initiation rate higher than 21% whilst
the vaccine initiation rate in the adolescent girl groups ranged from
27% to 57%. Public health and the media have focused much of the
HPV vaccine campaigns on girls [29] with particular attention to
the prevention of cervical cancer [6]. There is growing evidence
and greater information available regarding other HPV associated
cancers and genital warts and in time the importance and aware-
ness surrounding the need for this vaccine in boys should improve
[30]. As the vaccine program is new for boys, it is possible that the
85% initiation rate will increase over time similar to the girls pro-
gram which started with an 88% initiation rate in 2008, and had a
91% initiation rate in 2013.
There was a signiﬁcant difference between the English and
French Language School Boards with students from the French
Language School Board being less likely to be immunized. This sig-
niﬁcant difference was found when the outcome was  ≥1 dose, ≥2
doses, or fully immunized in the model and therefore was  a differ-
ence in terms of intention to vaccinate. Materials and consents are
provided to the schools in the appropriate language and follow-
up contact from a public health nurse is also conducted in the
appropriate language reducing the chance of unequal programs.
Returned consent forms and follow-up reminder calls by public
health nurses were found to have a signiﬁcant relationship with
HPV vaccine initiation based on a survey from Nova Scotia, Canada
of their school-based HPV program for girls [25].
Although the characteristics of families who  attend French Lan-
guage School Board schools are unknown, it is possible that there
may  be differences in parental education levels, household income,
culture, and religion compared with families in the English Lan-
guage School Board. These differences might account for some of
the difference seen between the two  school boards. Higher lev-
els of education of the parents or guardians have the potential to
decrease the likelihood of HPV vaccination [30,31]. It has also been
suggested that this difference in HPV uptake is not unique to the
HPV vaccine. This is something that we are currently investigating
to ascertain whether the immunization uptake for all publically
funded vaccines are lower in the French versus English language
schools.
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The school-based program is administered to grade 6 boys and
irls who are mostly 11–12 years old. Parental consent is required
nd parental beliefs are likely a fundamental limiting factor in
ptake rates. Several studies have looked at parental acceptabil-
ty for HPV vaccination in boys [2,29,32]. In the United States, it has
een shown that HPV vaccination recommendation from a health-
are provider is the key to having boys vaccinated [2]. Feeling that
PV vaccine was not needed, no provider recommendation, lack
f knowledge, son not sexually active, male, and safety and side
ffects (in that order) were the main reasons given for not opting
o vaccinate [2]. To address these parental concerns, the HPV vacci-
ation program administered by PEI Public Health Nursing, outlines
he beneﬁts of the vaccine and any safety and side effects issues.
he program also offers an opportunity for parents to ask ques-
ions to a public health nurse if they feel that their child should
ot be vaccinated. All components of this education were found
o have a positive relationship with HPV vaccine initiation and
ompletion for girls in a school-based survey in Canada [25]. A sur-
ey from the United States demonstrated that only 54% of parents
ntended to vaccinate their boys against HPV even when there were
o transportation or ﬁnancial barriers [30]. Those decisions were
ade based on perceived beneﬁt of HPV vaccine, general beneﬁt of
mmunizations, and spousal agreement.
The main strength of this prevalence study is that it is a census
tudy which included all children attending public schools in PEI
n grade 6. Individual vaccine records were accessible if there were
uspected data entry errors. It is estimated that only 25 additional
hildren of the appropriate age attend private school or are home-
chooled. They are not included in the analysis as it was  not possible
o acquire their identiﬁable health information. One weakness of
he study was that there were only a small number of students
ho attended schools in the French Language School Board (5.2%).
This study was able to identify that boys and students attending
chools in the French Language School Board were at higher risk of
ot being fully vaccinated for HPV. This fact will allow for a review of
he vaccine program with speciﬁc aims to increase uptake in these
roups. However, the reasons why these groups had lower uptakes
ere not determined. If attempts to increase uptake in these two
roups are not successful, perhaps focus group discussions led by
ublic health with parents of unvaccinated boys and unvaccinated
hildren in the French Language School Board may  be beneﬁcial in
etermining the knowledge gaps or hesitancy around the vaccine.
. Conclusions
HPV vaccination for boys in PEI has had a successful launch.
ith improved programming, uptake of vaccination in the boys
hould surpass the recommendations of >80% in the early years
f the program. PEI has a highly organized Public Health Nursing
rogram that is involved in all childhood and school-based vacci-
ations in PEI. Opportunities to speak with nurses educated in HPV
accination likely contributed to increased uptake and will con-
inue. Investigation into ways of improving uptake will continue as
ell. In addition, program evaluation should continue to monitor
hanging incidence of HPV associated conditions.
PEI, similar to other provinces, will be considering a two-dose
PV vaccination program in the future. If this signiﬁcant change is
ade, increased uptake for all grade 6 children may  be realized.
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